Latest Conference Articles

Excipients and Intended Use

May 1st 2026

In part 3 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, talks about the collaboration between the pharma company and the excipient supplier when different routes of administration are considered for an ingredient.

Avi Nandi on Simplifying Cell & Gene Supply Chains

May 1st 2026

Avi Nandi, SK Pharmteco, explores the benefits, challenges, and sustainability impact of on-site media and buffer manufacturing for cell & gene therapy.

Todd Vaughn and Christa Myers on What Robotics Mean for Pharma Manufacturing

April 30th 2026

Todd Vaughn and Christa Myers discuss how Robotics are reshaping aseptic pharmaceutical manufacturing by improving efficiency, repeatability, and compliance while demanding new operator skills.

Regulatory Involvement in Excipient Development

April 29th 2026

In part 2 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains what drives the need for the development of a new excipient and how involved regulators are in the process.

Stuart Tindal and David Chau on Sensors, Standards, and Shared Progress

April 29th 2026

Stuart Tindal and David Chau discuss spectroscopic sensor selection for continuous bioprocessing and how industry collaboration drives shared innovation.

The Challenge of Visual Inspection of Prefilled Syringes

April 29th 2026

Daniele Ansaldi, technical manager for Automated Inspection Machines at Antares Vision Group North America, outlines some of the challenges of performing visual inspections on prefilled syringes.

Richard Sanderson on EPCM vs. Construction Firms

April 29th 2026

Richard Sanderson, IPS, discusses pharma capital project cost pressures, bloated deliverable lists, and making the case for EPCM's end-to-end delivery model.

Why Loving Your Problem Is the Key to Smarter Pharma Process Optimization

April 28th 2026

At INTERPHEX 2026, Mel Radford, Bethany Silva, and Jason Pennington explore data trust, cybersecurity, organizational barriers, and KPI-driven thinking in smart pharma manufacturing adoption.

Leslie Weaver and George Hunt on Lean and Sustainability in Pharma Construction

April 28th 2026

Leslie Weaver and George Hunt, IPS, discuss early sustainability and lean alignment in pharma construction that reduce costs, absorb disruptions, and keep projects on schedule.

Point-of-Use Media Manufacturing Could Cut Bioprocessing's Carbon Footprint by Two Thirds

April 28th 2026

At INTERPHEX 2026, Bryan Poltilove highlights a novel technology as a promising point-of-use media manufacturing approach with major sustainability and logistical benefits.